Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
IDF-11774, is a novel hypoxia-inducible factor (HIF)-1 inhibitor with an IC50 of 3.65 μM in cancer cell line. It has shown to reduce capillary network formation on Matrigel, when human umbilical vascular endothelial cells (HUVECs) were treated with IDF-11774.
?您的位置：
